INSM
Price
$159.59
Change
-$0.53 (-0.33%)
Updated
Oct 24, 04:59 PM (EDT)
Capitalization
33.9B
6 days until earnings call
Intraday Buy/Sell Signals
THAR
Price
$3.00
Change
+$0.10 (+3.45%)
Updated
Oct 24, 10:48 AM (EDT)
Capitalization
20.54M
Intraday Buy/Sell Signals
Interact to see
Advertisement

INSM vs THAR

Header iconINSM vs THAR Comparison
Open Charts INSM vs THARBanner chart's image
Insmed
Price$159.59
Change-$0.53 (-0.33%)
Volume$25.7K
Capitalization33.9B
Tharimmune
Price$3.00
Change+$0.10 (+3.45%)
Volume$269
Capitalization20.54M
INSM vs THAR Comparison Chart in %
INSM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
THAR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
INSM vs. THAR commentary
Oct 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INSM is a StrongBuy and THAR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 24, 2025
Stock price -- (INSM: $160.12 vs. THAR: $2.90)
Brand notoriety: INSM and THAR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: INSM: 118% vs. THAR: 2%
Market capitalization -- INSM: $33.9B vs. THAR: $20.54M
INSM [@Biotechnology] is valued at $33.9B. THAR’s [@Biotechnology] market capitalization is $20.54M. The market cap for tickers in the [@Biotechnology] industry ranges from $108.36B to $0. The average market capitalization across the [@Biotechnology] industry is $2.03B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INSM’s FA Score shows that 1 FA rating(s) are green whileTHAR’s FA Score has 0 green FA rating(s).

  • INSM’s FA Score: 1 green, 4 red.
  • THAR’s FA Score: 0 green, 5 red.
According to our system of comparison, INSM is a better buy in the long-term than THAR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INSM’s TA Score shows that 2 TA indicator(s) are bullish while THAR’s TA Score has 3 bullish TA indicator(s).

  • INSM’s TA Score: 2 bullish, 6 bearish.
  • THAR’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, THAR is a better buy in the short-term than INSM.

Price Growth

INSM (@Biotechnology) experienced а -1.88% price change this week, while THAR (@Biotechnology) price change was +0.69% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.73%. For the same industry, the average monthly price growth was +11.03%, and the average quarterly price growth was +64.77%.

Reported Earning Dates

INSM is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Biotechnology (+0.73% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
INSM($33.9B) has a higher market cap than THAR($20.5M). INSM YTD gains are higher at: 131.924 vs. THAR (42.857). THAR has higher annual earnings (EBITDA): -11.99M vs. INSM (-938.1M). INSM has more cash in the bank: 1.86B vs. THAR (2.24M). THAR has less debt than INSM: THAR (250K) vs INSM (576M). INSM has higher revenues than THAR: INSM (398M) vs THAR (0).
INSMTHARINSM / THAR
Capitalization33.9B20.5M165,366%
EBITDA-938.1M-11.99M7,821%
Gain YTD131.92442.857308%
P/E RatioN/A0.02-
Revenue398M0-
Total Cash1.86B2.24M82,828%
Total Debt576M250K230,400%
FUNDAMENTALS RATINGS
INSM: Fundamental Ratings
INSM
OUTLOOK RATING
1..100
77
VALUATION
overvalued / fair valued / undervalued
1..100
71
Overvalued
PROFIT vs RISK RATING
1..100
4
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
36
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
INSMTHAR
RSI
ODDS (%)
Bearish Trend 2 days ago
73%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
75%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
71%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
69%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
73%
Bullish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
76%
Advances
ODDS (%)
Bullish Trend 5 days ago
70%
Bullish Trend 10 days ago
84%
Declines
ODDS (%)
Bearish Trend 2 days ago
74%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
78%
Bullish Trend 2 days ago
84%
Aroon
ODDS (%)
Bullish Trend 5 days ago
76%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
INSM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
THAR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
TDIV99.720.84
+0.85%
First Trust NASDAQ Technology Div ETF
BWTG38.270.08
+0.20%
Brendan Wood TopGun ETF
DVSP26.53N/A
N/A
WEBs Defined Volatility SPY ETF
ERH12.66-0.01
-0.08%
Allspring Utilities and High Income Fund
IGD5.86-0.03
-0.51%
Voya Global Equity Dividend AND Premium Opportunity Fund

INSM and

Correlation & Price change

A.I.dvisor indicates that over the last year, INSM has been closely correlated with THAR. These tickers have moved in lockstep 74% of the time. This A.I.-generated data suggests there is a high statistical probability that if INSM jumps, then THAR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INSM
1D Price
Change %
INSM100%
-0.17%
THAR - INSM
74%
Closely correlated
+7.41%
NUVL - INSM
45%
Loosely correlated
+0.01%
CRNX - INSM
42%
Loosely correlated
-0.87%
ROIV - INSM
42%
Loosely correlated
+1.40%
VRDN - INSM
41%
Loosely correlated
+0.78%
More